Zhenqin Zhang
Overview
Explore the profile of Zhenqin Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Y, Jiang Y, Jiang H, Qi X, Zhu L, Ju Y, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2024 Aug;
324:124993.
PMID: 39159512
BODIPY-based chemosensors are widely used owing to merits like good selectivity, high fluorescence quantum yield, and excellent optical stability. As such, a pH-switchable hydrophilic fluorescent probe, BODIPY-PY-(SONa), was developed for...
2.
Chen T, Yang Z, Zhang Z, Zhao Z, Guan J, Chen J, et al.
Appl Opt
. 2024 Jun;
63(12):3272-3276.
PMID: 38856477
Herein we report an electronically controlled tunable fiber-optic attenuator that leverages the microfluidic electro-wetting effect, which enables a fine-tuning of the solid-liquid interface wetting angle to control the micro-reflector, thus...
3.
Yang Y, Chen P, Liu Y, Cai Z, Wang X, Me Y, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2021 Jan;
251:119479.
PMID: 33503563
Determination of PPi levels in urine represents a measurable factor for diagnostic, treatment, and monitoring of urolithiasis. Owing to the quenching ability of Cu on fluorescent carbon dots (CDs) and...
4.
Jin S, Guo Y, Song D, Zhu Z, Zhang Z, Sun Y, et al.
Inorg Chem
. 2019 Apr;
58(9):6507-6516.
PMID: 31013065
Cancer is characterized by abnormal cellular energy metabolism, which preferentially switches to aerobic glycolysis rather than oxidative phosphorylation as a means of glucose metabolism. Many key enzymes involved in the...
5.
Wang K, Zhu C, He Y, Zhang Z, Zhou W, Muhammad N, et al.
Angew Chem Int Ed Engl
. 2019 Jan;
58(14):4638-4643.
PMID: 30693616
Cancer cells usually adapt metabolic phenotypes to chemotherapeutics. A defensive strategy against this flexibility is to modulate signaling pathways relevant to cancer bioenergetics. A triphenylphosphonium-modified terpyridine platinum(II) complex (TTP) was...
6.
Jin S, Hao Y, Zhu Z, Muhammad N, Zhang Z, Wang K, et al.
Inorg Chem
. 2018 Aug;
57(17):11135-11145.
PMID: 30117731
Platinum(IV) complexes are prodrugs of cisplatin with multiple potential advantages over platinum(II) drugs. Mitochondria play pivotal roles in producing energy and inducing death of cancer cells. Two platinum(IV) complexes, namely,...
7.
Zhang Z, Zhu Z, Luo C, Zhu C, Zhang C, Guo Z, et al.
Inorg Chem
. 2018 Mar;
57(6):3315-3322.
PMID: 29513007
Osteosarcoma (OS) is the most common primary pediatric bone tumor lethal to children and adolescents. Chemotherapeutic agents such as cisplatin are not effective for OS because of their poor accessibility...
8.
Zhang Z, Wang X, Luo C, Zhu C, Wang K, Zhang C, et al.
Chem Asian J
. 2017 May;
12(13):1659-1667.
PMID: 28556606
Osteosarcoma is the most common malignant bone tumor primarily affecting adolescents. Targeted platinum(II) complexes are promising candidates for overcoming the general toxicity of conventional platinum anticancer drugs. In this study...
9.
Yan J, Liu S, Zhang Z, He G, Zhou P, Liang H, et al.
Colloids Surf B Biointerfaces
. 2013 Jul;
111:392-7.
PMID: 23850748
Pd-Pt bimetallic nanoparticles anchored on functionalized reduced graphene oxide (RGO) nanomaterials were synthesized via a one-step in situ reduction process, in which Pt and Pd ions were first attached to...
10.
Peng H, Zhang Z, Qi R, Yao Y, Zhang Y, Shen Q, et al.
Inorg Chem
. 2008 Oct;
47(21):9828-35.
PMID: 18828586
The synthesis and reactivity of a series of sodium and rare-earth metal complexes stabilized by a dianionic N-aryloxo-functionalized beta-ketoiminate ligand were presented. The reaction of acetylacetone with 1 equiv of...